Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (19)	8/5/1999 9:57:00 AM
From: scaram(o)uche	Read Replies (2) of 1833

exchange2000.com What's Next? One of the major problems facing the pharmaceutical industry is secondary testing of potential drug candidates mined from the high-throughput screening systems. These drug candidates need to go through tests such as toxicity, hydrophobicity, and uptake studies like CACO-2 assays before they move farther along the drug development pathway. According to Hamilton Company's Engelhart, there is not much standardization for automating these kinds of tests. Furthermore, he's noticed the "ripple effect" in the industry as companies begin looking for labware, equipment, and personnel. Solving these problems, he says, "is the next big challenge for these companies."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next